http://news.prlog.org/tag/rna/rna - Latest News (Press Releases) - Read news before it's newsen-us3600 http://www.prlog.org/12116189-nanoparticles-boost-therapeutic-potential-of-sirna-drugs.htmlNew classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. http://www.prlog.org/12084947-drug-delivery-strategy-eliminates-myotonia-symptoms-in-mice-with-myotonic-dystrophy.htmlBy targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease. http://www.prlog.org/12080170-noncoding-rnas-offer-huge-therapeutic-and-diagnostic-potential.htmlAs scientists continue to unravel the complexity of the human genome and to uncover vital elements that play a role in both normal physiology and disease, one particular class of elements called noncoding RNAs is gaining a lot of attention. http://www.prlog.org/11877935-anaspec-showcases-fluorescent-nucleic-acid-probes.htmlThe detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection. http://www.prlog.org/11788904-new-rna-based-therapeutic-strategies-for-controlling-gene-expression.htmlSmall RNA-based nucleic acid drugs represent a promising new class of therapeutic agents for silencing abnormal or overactive disease-causing genes, and researchers have discovered new mechanisms by which RNA drugs can control gene activity. http://www.prlog.org/11765438-talk-on-origin-of-life-darwin-under-siege-at-shridhar-university-pilani-rajasthan.htmlEven though the proponents of a natural origin of life expressed much optimism for providing their theories, presently there is a detailed compilation of information seriously questioning this doctrine. http://www.prlog.org/11659522-gold-nuggets-for-biotechnology.htmlWhile the gold price keeps setting new records, nanoparticles from pure gold are also gaining importance in biotechnology. Particular GmbH from Germany now uses a laser method to produce them with high purity and conjugate them with high efficiency. http://www.prlog.org/11477328-cancer-researcher-discovers-natural-approach-for-cellular-protection-from-environmental-toxins.htmlNew Book “Extraordinary Healing” recounts life and research of French molecular biologist Dr. Mirko Beljanski http://www.prlog.org/11325621-insight-pharma-reports-rnai-therapeutics-report.htmlRNAi Therapeutics: Second-Generation Candidates Build Momentum http://www.prlog.org/11122028-currently-available-techniques-and-products-in-the-mirna-market-available-through-bharatbook.htmlBharatbook added a new report on "Global miRNA Market Outlook" which provides a comprehensive overview of the miRNA market and its prospects. By RNCOS. http://www.prlog.org/11050192-danforth-plant-science-center-announces-new-president.htmlDr. William H. Danforth, chairman of the Board of Trustees of the Donald Danforth Plant Science Center, today announced that Dr. James C. Carrington, will become the next President of the Danforth Plant Science Center. http://www.prlog.org/11023140-new-market-research-report-next-generation-sequencing-technologies-applications-and-markets.htmlCambridge Healthtech Institute (CHI) releases its latest Insight Pharma Report, Next-Generation Sequencing Technologies: Applications and Markets, available at InsightPharmaReports.com http://www.prlog.org/11016471-promising-new-antigene-therapy-uses-light-energy-to-silence-gene-activity.htmlAntigene therapy is a promising new treatment strategy that uses a DNA-based drug to pinpoint light energy to a target gene shutting down its activity. A review article published online ahead of print in Oligonucleotides. http://www.prlog.org/10802961-new-range-of-electrophoresis-power-supplies-from-serva.htmlSERVA Electrophoresis introduce the Blue Power range of Programmable Laboratory Power Supplies. http://www.prlog.org/10801953-ethidium-bromide-replacement-therapy.htmlSERVA DNA Stain G is a safer alternative to traditional ethidium bromide stain for detecting nucleic acid in agarose gels. http://www.prlog.org/10521529-levelstockcom-transgenomic-presents-at-12th-annual-bio-ceo-investor-conference.htmlInvestors seeking technical and fundamental stock alerts on penny stocks can subscribe to our newsletters today at LevelStock.com http://www.prlog.org/10519004-tacere-therapeutics-achieves-significant-milestone-in-collaboration-license-agreement-with-pfizer.htmlPfizer exercises option to further develop and commercialize Tacere’s Hepatitis C Virus (HCV) compounds. http://www.prlog.org/10517194-ribonucleic-acid-rnatherapeutics-strong-potential-to-address-unmet-needs-in-pharma-by-bharatbook.htmlBharatbook added a new report on "Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma" which gives in-depth analysis on RNA Therapeutics Market. http://www.prlog.org/10460622-stapled-peptides-can-open-new-routes-to-new-therapy-approaches-for-multiple-diseases.htmlBio-Synthesis, Inc. provides custom products for researchers and pharmaceutical companies http://www.prlog.org/10426299-the-benefits-of-antidrug-antibodies.htmlThe new uses and benefits of anti-drug antibodies, examined by Bio-Synthesis, Inc. http://www.prlog.org/10402737-biosynthesis-gears-up-for-virtual-conference-for-the-life-sciences.htmlBio-Synthesis has teamed up with BioConference Live for a revolutionary event. BioConference Live is a free, online-only conference for the life sciences and laboratory science community. http://www.prlog.org/10354657-genus-biosystems-announces-combined-mirna-and-whole-genome-gene-expression-service.htmlGenUs BioSystems announces a combined miRNA and whole genome gene expression service. Standard combined service for yields as low as 400 nanograms. Special application services are also available for much smaller yields. http://www.prlog.org/10354635-genus-biosystems-reduces-yield-requirement-for-gene-expression-rna-samples.htmlGenUs BioSystems announces a 70% reduction in the minimum RNA yield requirement for standard gene expression services to 300 nanograms. Special services are available for yields down to 100 picograms RNA. http://www.prlog.org/10301835-new-dna-and-rna-aptamers-offer-unique-therapeutic-advantages.htmlA novel class of drugs composed of single strands of DNA or RNA, called aptamers, can bind protein targets with a high strength and specificity and are currently in clinical development as treatments for a broad range of common diseases http://www.prlog.org/10240296-strong-immune-response-to-new-sirna-drugs-in-development-may-cause-toxic-side-effects.htmlSmall synthetic fragments of genetic material called small interfering RNA (siRNA) can block production of abnormal proteins; however, these exciting new drug candidates can also induce a strong immune response, causing toxic side effects http://www.prlog.org/10230869-trana-discovery-featured-on-radio-in-vivo.htmlDrug discovery technology company develops tools to find new treatments for serious infectious diseases… http://www.prlog.org/10146586-colfax-international-and-rna-networks-partner-to-deliver-breakthrough-performance-gains.htmlRNA Networks’ Memory Virtualization Platform Improves HPC Performance and Analysis http://www.prlog.org/10129974-genetic-engineering-biotechnology-news-reports-on-novel-tools-for-deciphering-biological-networks.htmlSystems biology scientists from diverse areas of research are developing a range of methods to model pathways, interpret data, and derive therapeutic targets from biological networks, reports Genetic Engineering and Biotechnology News (GEN). http://www.prlog.org/10129915-bharatbook-announces-to-distribute-rna-interference-markets-report.htmlBharatbook.com is glad to promote new report which focuses on RNA interference markets http://www.prlog.org/10047112-the-rna-drug-revolution-new-approach-to-gene-therapy.htmlRNAi represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing applications of RNAi and microRNAs will begin in Human Gene Therapy.